Literature DB >> 17521493

Neuropsychological outcomes in children of mothers with epilepsy.

Elisa Kantola-Sorsa1, Eija Gaily, Mirva Isoaho, Marit Korkman.   

Abstract

The study investigated the nature of the effects of maternal epilepsy on cognitive performance of the offspring. One hundred fifty-four children of mothers with epilepsy aged 5 to 11 years (study group), along with 130 control children, comparable with respect to IQ, socio-economic status, age, and gender underwent a neuropsychological assessment using subtests from the NEPSY: A Developmental Neuropsychological Assessment, tapping attentional, auditory-verbal, visuomotor, fine motor, and memory abilities. The study group scored significantly lower than the controls on measures of attention, memory, and fine-motor function. Deficits were more marked in but not limited to the subset of the study group exposed to maternal medication in utero. Group differences on auditory attention were found only in younger children. Valproate-exposed children obtained lower scores on sentence repetition, as well as on the more demanding part of a test of auditory attention, than other children in the study group, suggesting weaknesses in working memory in the former subgroup. Confounding by maternal epilepsy type and polytherapy complicate interpretation of this finding. Differences between subsets of children not exposed to anti-epileptic drugs in utero and controls suggest that both drug exposure and genetic factors may contribute to cognitive deficits associated with maternal epilepsy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521493     DOI: 10.1017/S1355617707070804

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  7 in total

1.  [Valproate for treatment of women with epilepsy: recommendations of the German Society for Epileptology].

Authors:  B Schmitz; D Dennig; D Rating; B J Steinhoff; T Mayer
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

2.  Child development following in utero exposure: levetiracetam vs sodium valproate.

Authors:  R Shallcross; R L Bromley; B Irwin; L J Bonnett; J Morrow; G A Baker
Journal:  Neurology       Date:  2011-01-25       Impact factor: 9.910

Review 3.  Antiepileptic drugs and pregnancy outcomes.

Authors:  Bogdan J Wlodarczyk; Ana M Palacios; Timothy M George; Richard H Finnell
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

Review 4.  Teratogenic effects of antiepileptic drugs.

Authors:  Denise S Hill; Bogdan J Wlodarczyk; Ana M Palacios; Richard H Finnell
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

Review 5.  Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero.

Authors:  Rebecca L Bromley; Gus A Baker; Kimford J Meador
Journal:  Curr Opin Neurol       Date:  2009-04       Impact factor: 5.710

Review 6.  Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Authors:  Rebecca Bromley; Jennifer Weston; Naghme Adab; Janette Greenhalgh; Anna Sanniti; Andrew J McKay; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2014-10-30

Review 7.  Neurodevelopment Following Exposure to Antiseizure Medications in Utero: A Review.

Authors:  Rebecca L Bromley; Matthew Bluett-Duncan
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.